Bicalutamide Tablet, Film Coated
Product Images NDC 47335-485

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bicalutamide (NDC 47335-485). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bicalutamide-figure-1 (Bicalutamide Figure 1)

The text describes a figure labeled "Figure 1" that shows the probability of death for two groups receiving different antiandrogen treatments. The figure is a graph with a line graph showing the Kaplan-Meier probability of death on the y-axis and the time since trial start on the x-axis. The two groups being compared are identified as "Bicalutamide plus LHRH-A" and "Flutamide plus LHRH-A". The proportion of individuals surviving is also shown on the y-axis. The time since the start of the trial is measured in days and ranges from 0 to 1825.*

FDA Label Image

Bicalutamide-figure-2 (Bicalutamide Figure 2)

The text describes a figure labeled "Figure 2" that consists of a Kaplan-Meier curve representing the time to progression for two antiandrogen treatment groups. The proportion not progressing is shown on the y-axis ranging from 0.3 to 1.0, while the x-axis represents the days to progression ranging from 0 to 1825. The two antiandrogen treatments compared are bicalutamide plus LHRH-A and flutamide plus LHRH-A.*

FDA Label Image

Bicalutamide-structure (Bicalutamide Structure)

Not available.*

FDA Label Image

Spl Bicalutamide Tablets

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.